Topotecan in Treating Patients With Recurrent Brain Tumors
Status:
Completed
Trial end date:
2009-12-21
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of topotecan in treating patients with
recurrent brain tumor.